Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
You'll get FREE Breaking News Alerts on new MS treatments as they are approved

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
Medical Director-Rocky Mountain MS Center

Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

This page is powered by Blogger. Isn't yours?



Know which questions to ask your neurologist about MRIs

I’m sure all of us with MS have had at least one magnetic resonance imaging (MRI) scan. Most likely, more than one.

MRIs are designed to scan and provide detailed pictures of the body, the brain included.

The test can reveal scars (plaque lesions) on the brain and the spinal cord. Even though there are no  definitive tests for MS, the plaque lesions that appear on MRI photos can be a good indication that MS is the culprit.

In my experiences in dealing with MRI reports I have been left feeling I wasn’t given the whole story. Maybe I didn’t ask the correct questions, but my doctor didn’t offer any pertinent information, either.

The 2016 summer issue of Momentum Magazine, published by the national MS Society, has a very good article by Susan Worley titled Demystifying MRIs. It discusses that MRIs offer useful information. But it also shines light on the fact they are limited in what they can report.

The main information in the article comes from Daniel Reich, MD, , of the National Institutes of Health.

He states that the majority of lesions that show up on MRIs do not have symptoms or relapses associated with them. So, it can be very difficult for experts to predict what path new lesions will take.

It is unknown if the lesions will produce symptoms or if they will repair themselves. He says lesion repair is part of the reason people recover from relapses.

Reich adds that another difficulty of reading MRIs is “whenever there is new inflammation in the body there tends to be a lot of swelling, which causes more water than usual between the cells of the brain.” He adds that the water makes it difficult to see “how much of the myelin and how many of the nerve cells have been damaged.”

Knowing the correct questions to ask may help decipher some of the unknowns of MS.

Another doctor mentioned in the article is Lily Henson, MD, of Piedmont Healthcare in Atlanta. She offers some questions that you can ask your neurologist when going over your MRI report, and suggests letting your doctor know if there is something you don’t understand.

Ask questions such as: “Do you see any new scars or any evidence of permanent nerve cell loss?” Ask if there were any changes on the MRI because those changes can lead to disability.

Hansen said “Even when no new scarring is apparent, the scars that have occurred in the past are still there, and there could be activity occurring underneath the surface.”

She ends with “perhaps most importantly the absence of new lesions doesn’t mean that a patient can start thinking about discontinuing his or her medications. Previous activity may be under control because of the disease-modifying agent a patient is taking.”

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length
Click here to read more

Go to Newer News Go to Older News